Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Opdivo's survival benefit inspired FDA to act fast on NSCLC approval: Pazdur
Opdivo's survival benefit inspired FDA to act fast on NSCLC approval: Pazdur
Opdivo's survival benefit inspired FDA to act fast on NSCLC approval: Pazdur
Submitted by
admin
on March 9, 2015 - 2:52pm
Source:
Fierce Pharma
News Tags:
FDA
Bristol-Myers Squibb
Opdivo
non-small cell lung cancer
Headline:
Opdivo's survival benefit inspired FDA to act fast on NSCLC approval: Pazdur
Do Not Allow Advertisers to Use My Personal information
